PL329243A1 - Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo [3.2.1] octane, their production and application in therapy - Google Patents

Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo [3.2.1] octane, their production and application in therapy

Info

Publication number
PL329243A1
PL329243A1 PL97329243A PL32924397A PL329243A1 PL 329243 A1 PL329243 A1 PL 329243A1 PL 97329243 A PL97329243 A PL 97329243A PL 32924397 A PL32924397 A PL 32924397A PL 329243 A1 PL329243 A1 PL 329243A1
Authority
PL
Poland
Prior art keywords
tetrahydroisoquinolin
azabicyclo
octane
therapy
derivatives
Prior art date
Application number
PL97329243A
Inventor
Mireille Sevrin
Benoit Marabout
Pascal George
Jean-Pierre Merly
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of PL329243A1 publication Critical patent/PL329243A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL97329243A 1996-04-12 1997-04-10 Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo [3.2.1] octane, their production and application in therapy PL329243A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9604565A FR2747386B1 (en) 1996-04-12 1996-04-12 DERIVATIVES OF 3 - [(1,2,3,4-TETRAHYDROISOQUINOLEIN-2-YL) METHYL] -8-AZABICYCLO [3.2.1] OCTANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PCT/FR1997/000634 WO1997038998A1 (en) 1996-04-12 1997-04-10 3-[(1,2,3,4-tetrahydroisoquinoline-2-yl)methyl]-8-azabicyclo[3.2.1]octane derivatives, their preparation and their application in therapeutics

Publications (1)

Publication Number Publication Date
PL329243A1 true PL329243A1 (en) 1999-03-15

Family

ID=9491132

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97329243A PL329243A1 (en) 1996-04-12 1997-04-10 Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo [3.2.1] octane, their production and application in therapy

Country Status (22)

Country Link
EP (1) EP0892800A1 (en)
JP (1) JP2000512620A (en)
KR (1) KR20000005392A (en)
CN (1) CN1216046A (en)
AR (1) AR008587A1 (en)
AU (1) AU2640997A (en)
BG (1) BG102779A (en)
BR (1) BR9708654A (en)
CA (1) CA2251335A1 (en)
CO (1) CO4900067A1 (en)
CZ (1) CZ326898A3 (en)
EE (1) EE9800396A (en)
FR (1) FR2747386B1 (en)
IL (1) IL126473A0 (en)
NO (1) NO984736L (en)
NZ (1) NZ332257A (en)
PL (1) PL329243A1 (en)
SK (1) SK141598A3 (en)
TR (1) TR199801839T2 (en)
TW (1) TW407158B (en)
WO (1) WO1997038998A1 (en)
ZA (1) ZA973124B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011525893A (en) * 2008-06-27 2011-09-29 ハー・ルンドベック・アクチエゼルスカベット Novel phenolamines and catecholamines and their prodrugs
US10870660B2 (en) 2016-07-28 2020-12-22 Shionogi & Co., Ltd. Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect
EP3744721A4 (en) 2018-01-26 2021-11-10 Shionogi & Co., Ltd Condensed cyclic compound having dopamine d3 receptor antagonism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
EP0306375A1 (en) * 1987-08-07 1989-03-08 Synthelabo 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their use in therapy
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
FR2661178B1 (en) * 1990-04-24 1993-03-12 Synthelabo DERIVATIVES OF [(TETRAHYDRO-1,2,3,4 ISOQUINOLEINYL-2) METHYL] -4 PIPERIDINECARBOXYLATES-1 OF ALKYL, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Also Published As

Publication number Publication date
CZ326898A3 (en) 1999-01-13
FR2747386A1 (en) 1997-10-17
KR20000005392A (en) 2000-01-25
AR008587A1 (en) 2000-02-09
AU2640997A (en) 1997-11-07
TW407158B (en) 2000-10-01
TR199801839T2 (en) 1998-12-21
EP0892800A1 (en) 1999-01-27
IL126473A0 (en) 1999-08-17
BG102779A (en) 1999-09-30
SK141598A3 (en) 1999-03-12
BR9708654A (en) 1999-08-03
CO4900067A1 (en) 2000-03-27
CA2251335A1 (en) 1997-10-23
EE9800396A (en) 1999-06-15
CN1216046A (en) 1999-05-05
JP2000512620A (en) 2000-09-26
FR2747386B1 (en) 1998-05-15
NO984736L (en) 1998-11-23
NO984736D0 (en) 1998-10-09
ZA973124B (en) 1997-11-05
NZ332257A (en) 1999-03-29
WO1997038998A1 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
HUP9802433A3 (en) 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use
AU4394897A (en) Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and the ir use in addiction therapy
EP0690023A3 (en) Xerogels, process for their preparation and their use
EP0756636A4 (en) Chondroitinases i and ii, methods of preparation, and use thereof
AU8487191A (en) 2-aminopyrimidine-4-caroxamide derivatives, their preparation and their use in therapy
ZA978089B (en) 3,4-diaryloxazolone derivatives, their methods of preparation, and their use in therapeutics.
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
ZA885150B (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
ZA963485B (en) Azacycloalkane derivatives, their preparation and their application in therapy
NZ325587A (en) 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity
IL108343A0 (en) 9H-imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application
ZA978772B (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives, their preparation and their use in therapy.
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
PL329243A1 (en) Derivatives of 3-[(1,2,3,4-tetrahydroisoquinolin-2-yl)methyl]-8-azabicyclo [3.2.1] octane, their production and application in therapy
AU3650695A (en) New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
ZA982369B (en) Dihydropyrazino[1,2-a]indol-1-one derivatives their preparation and their use in therapy
AU627033B2 (en) 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives, their preparation and their application in therapy
AU5975094A (en) 1,2,4-triazinone derivatives and their use in therapy
ZA976828B (en) 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine-3-acetic acid derivatives, their preparation and their application in therapy.
ZA953749B (en) 5,6-dihydro-4H-thieno[3,4-c] pyrroie derivatives their preparation and their therapeutic application
AU4096689A (en) The use of lactam derivatives in the treatment of addiction
HUP9700628A2 (en) 4-thia-1-aza-bicyclo[3.2.0]heptan-3-imino-2-izopropiliden-7-oxo-beta-lactame derivatives, process for producing them and use of them
EP0699719A3 (en) Azodyes, process for their preparation and the use thereof
ZA984639B (en) 8-Azabicyclo [3.2.1]oct-2-ene and octane derivatives their preparation and use